111 related articles for article (PubMed ID: 9056484)
1. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding.
Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA
Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities.
Rocque WJ; Tian G; Wiseman JS; Holmes WD; Zajac-Thompson I; Willard DH; Patel IR; Wisely GB; Clay WC; Kadwell SH; Hoffman CR; Luther MA
Biochemistry; 1997 Nov; 36(46):14250-61. PubMed ID: 9369498
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of human type 4 phosphodiesterase isostates by (R, R)-(+/-)-methyl 3-acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate.
Tian G; Rocque WJ; Wiseman JS; Thompson IZ; Holmes WD; Domanico PL; Stafford JA; Feldman PL; Luther MA
Biochemistry; 1998 May; 37(19):6894-904. PubMed ID: 9578576
[TBL] [Abstract][Full Text] [Related]
4. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
[TBL] [Abstract][Full Text] [Related]
5. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
6. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP
J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798
[TBL] [Abstract][Full Text] [Related]
8. CDP840: a novel inhibitor of PDE-4.
Perry MJ; O'Connell J; Walker C; Crabbe T; Baldock D; Russell A; Lumb S; Huang Z; Howat D; Allen R; Merriman M; Walls J; Daniel T; Hughes B; Laliberte F; Higgs GA; Owens RJ
Cell Biochem Biophys; 1998; 29(1-2):113-32. PubMed ID: 9631241
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase.
Lenhard JM; Kassel DB; Rocque WJ; Hamacher L; Holmes WD; Patel I; Hoffman C; Luther M
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):751-8. PubMed ID: 8670148
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT
J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two human cAMP-specific phosphodiesterase subtypes expressed in baculovirus-infected insect cells.
Amegadzie BY; Hanning CR; McLaughlin MM; Burman M; Cieslinski LB; Livi GP; Torphy TJ
Cell Biol Int; 1995 Jun; 19(6):477-84. PubMed ID: 7640661
[TBL] [Abstract][Full Text] [Related]
13. Expression, refolding, and purification of recombinant human phosphodiesterase 3B: definition of the N-terminus of the catalytic core.
Varnerin JP; Chung CC; Patel SB; Scapin G; Parmee ER; Morin NR; MacNeil DJ; Cully DF; Van der Ploeg LH; Tota MR
Protein Expr Purif; 2004 Jun; 35(2):225-36. PubMed ID: 15135397
[TBL] [Abstract][Full Text] [Related]
14. Recombinant expression of a type IV, cAMP-specific phosphodiesterase: characterization and structure-function studies of deletion mutants.
Kovala T; Sanwal BD; Ball EH
Biochemistry; 1997 Mar; 36(10):2968-76. PubMed ID: 9062127
[TBL] [Abstract][Full Text] [Related]
15. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
16. Purification and physical characterization of cloned human cAMP phosphodiesterases PDE-4D and -4C.
Saldou N; Baecker PA; Li B; Yuan Z; Obernolte R; Ratzliff J; Osen E; Jarnagin K; Shelton ER
Cell Biochem Biophys; 1998; 28(2-3):187-217. PubMed ID: 9515166
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells.
Lario PI; Bobechko B; Bateman K; Kelly J; Vrielink A; Huang Z
Arch Biochem Biophys; 2001 Oct; 394(1):54-60. PubMed ID: 11566027
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays.
Pon DJ; Plant M; Tkach J; Boulet L; Muise E; Allen RA; Rodger IW
Cell Biochem Biophys; 1998; 29(1-2):159-78. PubMed ID: 9631244
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the relationship between protein-protein interaction and catalytic activity of a heme-regulated phosphodiesterase from Escherichia coli (Ec DOS) by protein microarray.
Sasakura Y; Kanda K; Yoshimura-Suzuki T; Matsui T; Fukuzono S; Shimizu T
Biochemistry; 2005 Jul; 44(28):9598-605. PubMed ID: 16008345
[TBL] [Abstract][Full Text] [Related]
20. Zinc dependent activation of cAMP-specific phosphodiesterase (PDE4A).
Percival MD; Yeh B; Falgueyret JP
Biochem Biophys Res Commun; 1997 Dec; 241(1):175-80. PubMed ID: 9405253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
